Mortality News and Research

RSS

Serological antibody response to SARS-CoV-2 infection at a population level

The scientists in this study used pooled convalescent serum to examine the serologic response in a population at risk of infection.

6 Jan 2022

COVID boosters hinder SARS-CoV-2 Omicron

A new preprint research paper reports on the state of current knowledge as to the immune evasion capability of this variant, linking it to the type of vaccine used and the vaccination protocol.

6 Jan 2022

Mental health conservatorships led to lengthy inpatient stays among homeless people with mental illness

At a time when public and private agencies and the legal system are grappling with how to best assist people who live at the intersection of homelessness and mental illness during a global pandemic, UCLA researchers have found mental health conservatorships for people with disabling, severe mental illness who are also homeless can result in lengthy psychiatric hospitalizations.

6 Jan 2022

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

The LIVE-AIR phase 3 clinical trial is associated with early treatment of hyperinflammatory response with the humanized monoclonal antibody lenzilumab in COVID-19 patients with decreased oxygen saturation. The study results are posted to the medRxiv* preprint server.

6 Jan 2022

A new model for predicting COVID-19 severity at diagnosis

Researchers estimate the probabilities of hospitalization and mortality from COVID-19 according to individual risk factors and number of vaccine doses.

5 Jan 2022

Analyzing cell-free RNA could reliably predict preeclampsia

Imaging techniques such as ultrasound technologies and minimally invasive procedures are powerful tools for assessing pregnancy health and progression.

5 Jan 2022

Statistical analysis reveals less severe COVID-19 outcome due to Omicron variant

A new study demonstrated that in the US, the COVID-19 cases arising after the emergence of the SARS-CoV-2 Omicron variant showed reduced severity of infection than in the cases recorded in previous time points (during the Delta variant outbreak).

5 Jan 2022

COVID-19 mRNA vaccines offer protection against Omicron variant in pregnancy

A new study provides insights into the persistence of extra-neutralizing properties of mRNA vaccine-induced antibodies resulting in protection against the Omicron variant of SARS-CoV-2.

5 Jan 2022

Efficacy of COVID-19 convalescent plasma therapy in patients with hematological malignancies and COVID-19

Scientists recently demonstrated the efficacy of COVID-19 convalescent plasma therapy in improving the survival rate among patients with B-cell lymphoid malignancy and COVID-19.

5 Jan 2022

Basic health beliefs and demographics associated with risk factors for cardiovascular disease

Minnesota has the lowest age-adjusted heart disease mortality in the U.S.; yet, African American adults 35 to 63 have nearly double the rate of death from cardiovascular disease, compared to their white counterparts.

5 Jan 2022

Transplant recipients benefit from a COVID-19 vaccine booster

A new preprint research paper posted to the medRxiv* server describes the reduction in humoral immunity in SOTR following vaccination, as well as the improvement with an additional dose of the vaccine.

4 Jan 2022

Time since COVID vaccination is a key driver of breakthrough Omicron infections

Published on the preprint medRxiv* server and awaiting peer review, the findings showed that the significant factor behind breakthrough Omicron infections is the timing from vaccination. The time between vaccination and breakthrough infections induced effective or cross-reactive neutralizing antibodies that neutralize Omicron after Alpha or Delta breakthrough infections.

4 Jan 2022

Both symptomatic and asymptomatic COVID-19 associated with increased risk of cardiovascular events

Researcers determine the risk of symptomatic and asymptomatic SARS-CoV-2 infection on post-acute cardiovascular events and all-cause mortality.

4 Jan 2022

Study finds no evidence to link in-person schooling and SARS-CoV-2 community incidence

A new study led by faculty at Binghamton University, State University of New York shows that COVID-19 incidence rates were not statistically different in counties with in-person learning versus remote school modes in most regions of the U.S.

4 Jan 2022

Characteristics and outcomes in patients hospitalized with COVID-19 in South Africa

A new research letter assessed patients hospitalized with a positive SARS-CoV-2 test during the fourth wave compared to the previous waves.

4 Jan 2022

Modeling shows SARS-CoV-2 Omicron will place a severe burden on UK's health services

Researchers use data and a mathematical model to determine the impact of the SARS-CoV-2 Omicron variant on future risk of infection.

3 Jan 2022

CDC report shows COVID vaccines safe for children, serious side effects rare

Researchers determine the characteristics and clinical outcomes of COVID-19 in children and adolescents 18 years or younger.

3 Jan 2022

Olfactory receptor gene may play a role in breast cancer metastasis to the brain

An olfactory receptor gene that aids in the sense of smell may also play a role in the metastasis of breast cancer to the brain, bones and lung, researchers from Massachusetts General Hospital (MGH) have found.

3 Jan 2022

Scientists analyze the causes of deaths and disabilities in Colorado over a 29-year period

Scientists at Colorado State University used one of the most comprehensive global health datasets in the world to analyze the causes of deaths and disabilities in Colorado over a 29-year period, from 1990 to 2019.

3 Jan 2022

Hypertension-related maternal mortality rates continue to increase in the United States

Chronic hypertension is contributing substantially to maternal deaths in the United States, with particular risk among Black women, according to new research from Rutgers Robert Wood Johnson Medical School's Department of Obstetrics, Gynecology and Reproductive Sciences.

3 Jan 2022

Mortality News and Research

Serological antibody response to SARS-CoV-2 infection at a population level

COVID boosters hinder SARS-CoV-2 Omicron

Mental health conservatorships led to lengthy inpatient stays among homeless people with mental illness

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

A new model for predicting COVID-19 severity at diagnosis

Analyzing cell-free RNA could reliably predict preeclampsia

Statistical analysis reveals less severe COVID-19 outcome due to Omicron variant

COVID-19 mRNA vaccines offer protection against Omicron variant in pregnancy

Efficacy of COVID-19 convalescent plasma therapy in patients with hematological malignancies and COVID-19

Basic health beliefs and demographics associated with risk factors for cardiovascular disease

Transplant recipients benefit from a COVID-19 vaccine booster

Time since COVID vaccination is a key driver of breakthrough Omicron infections

Both symptomatic and asymptomatic COVID-19 associated with increased risk of cardiovascular events

Study finds no evidence to link in-person schooling and SARS-CoV-2 community incidence

Characteristics and outcomes in patients hospitalized with COVID-19 in South Africa

Modeling shows SARS-CoV-2 Omicron will place a severe burden on UK's health services

CDC report shows COVID vaccines safe for children, serious side effects rare

Olfactory receptor gene may play a role in breast cancer metastasis to the brain

Scientists analyze the causes of deaths and disabilities in Colorado over a 29-year period

Hypertension-related maternal mortality rates continue to increase in the United States

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News